Glycerophospholipid synthesis

Glycerophospholipid synthesis is a fundamental metabolic pathway responsible for the production and remodeling of glycerophospholipids, which serve as the primary structural components of all biological membranes (KEGG: map00564). This pathway, which includes the Kennedy pathway and the Lands cycle, is essential for maintaining cellular architecture, facilitating vesicle trafficking, and providing precursors for bioactive signaling molecules like diacylglycerol and arachidonic acid (PubMed: 22507677). In various pathological states, most notably cancer, glycerophospholipid metabolism is frequently reprogrammed to support the high demand for membrane biogenesis required for rapid cell proliferation (PubMed: 25236015). Consequently, specific enzymes within this pathway, such as choline kinase alpha (CHKα) and various phospholipases, have become significant focal points for drug development (PubMed: 23563486). While targeting these enzymes offers a strategy to inhibit tumor growth and inflammation, the essential role of glycerophospholipids in normal physiological functions poses a challenge for achieving a favorable therapeutic index without causing systemic toxicity (StatPearls: Biochemistry, Lipid Metabolism).

Other names

Phospholipid biosynthesisGlycerophospholipid metabolismGPL synthesisDe novo phospholipid synthesis

Inhibition of rate-limiting enzymes within the glycerophospholipid biosynthetic pathway, such as choline kinase alpha or phospholipase A2, to disrupt membrane integrity, reduce proliferative capacity, or modulate the production of pro-inflammatory lipid mediators.